Accolade (ACCD) Scheduled to Post Quarterly Earnings on Thursday

Accolade (NASDAQ:ACCDGet Free Report) will announce its earnings results after the market closes on Thursday, April 25th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Accolade Trading Up 1.5 %

ACCD opened at $9.35 on Wednesday. The firm has a market capitalization of $723.78 million, a price-to-earnings ratio of -5.67 and a beta of 2.08. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.35 and a quick ratio of 2.35. The company’s 50 day simple moving average is $9.90 and its two-hundred day simple moving average is $9.92. Accolade has a 1-year low of $6.33 and a 1-year high of $17.00.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ACCD. Needham & Company LLC reaffirmed a “buy” rating and set a $17.00 price target on shares of Accolade in a research report on Friday, January 19th. Piper Sandler boosted their target price on Accolade from $12.00 to $15.00 and gave the company an “overweight” rating in a research report on Tuesday, January 9th. William Blair reissued an “outperform” rating on shares of Accolade in a research report on Tuesday, January 9th. Raymond James boosted their target price on Accolade from $12.00 to $16.00 and gave the company an “outperform” rating in a research report on Tuesday, January 9th. Finally, Stifel Nicolaus dropped their price target on shares of Accolade from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Monday. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $15.53.

Read Our Latest Stock Report on Accolade

Accolade Company Profile

(Get Free Report)

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.

Further Reading

Earnings History for Accolade (NASDAQ:ACCD)

Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.